BeStock  
Markets › Compare › PTCT vs BLTE

PTCT vs BLTE

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
PTCT · PTC Therapeutics$56.42 ▼ 3.27%
BLTE · Belite Bio$127.38 ▼ 15.65%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

6686107127147Nov 24, '25May 26, '26Nov 20, '26
  • PTCT -29.3%
  • BLTE -6.3%

Head to head

MetricPTCTBLTE
Price$56.42$127.38
Change today▼ 3.27%▼ 15.65%
Market cap$4.71B$5.17B
Return, 3 months-20.6%-19.8%
Return, year to date-25.7%-20.4%
Return, 1 year-28.1%+5.7%
P/E (TTM)––
P/B-24.66.7
P/E percentile vs own 5y6th40th
Dividend yield––
Revenue growth (YoY, latest qtr)+69.6%–
Net profit growth (YoY)-425.2%-39.6%
Gross margin93.2%–
Operating margin12.0%–
Net margin-9.2%–
Return on equity–-21.2%
Analyst target vs. price+77.2%+81.9%
Analyst buy share83%100%
RSI (14)3432
30-day volatility54.4%74.4%
Max drawdown, 1 year-37.0%-34.2%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • BLTE is the largest of the group by market value.
  • BLTE has returned the most over the past year.
  • PTCT has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top